Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT7 | Q11130 | 1/20 | 0.35 |
| ▸ | EEF2K | O00418 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EBP | Q15125 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11786226 | 1.00 | FUT7 (0.35) | FUT7EEF2KKCNH2RECQLGLA | |
| SCHEMBL9810141 | 1.00 | FUT7 (0.35) | FUT7EEF2KKCNH2RECQLGLA | |
| SCHEMBL8167967 | 0.91 | FUT7 (0.35) | FUT7KCNH2RECQLGLAHPGD | |
| SCHEMBL4157139 | 0.87 | FUT7 (0.36) | FUT7KCNH2RECQLGLAHPGD | |
| SCHEMBL1027683 | 0.87 | FUT7 (0.36) | FUT7KCNH2RECQLGLAHPGD | |
| SCHEMBL1029399 | 0.87 | FUT7 (0.36) | FUT7KCNH2RECQLGLAHPGD | |
| SCHEMBL11786198 | 0.83 | EEF2K (0.38) | FUT7EEF2KKCNH2 | |
| SCHEMBL9814361 | 0.76 | KCNH2 (0.41) | KCNH2TSHRALDH1A1 | |
| SCHEMBL9814357 | 0.76 | KCNH2 (0.41) | KCNH2TSHRALDH1A1 | |
| SCHEMBL9772737 | 0.72 | MEN1 (0.38) | MAPK1EPHX2ALDH1A1MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035863-A1 | SOFT, LOW LINT, THROUGH AIR DRIED TISSUE AND METHOD OF FORMING THE SAME | FIRST QUALITY TISSUE LLC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12460354-B2 | Soft, low lint, through air dried roll bath tissue | FIRST QUALITY TISSUE, LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12180656-B2 | Systems and methods for application of surface chemistry to bath tissue, facial tissue, and paper towel | FIRST QUALITY TISSUE, LLC (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240218605-A1 | SOFT TISSUE PRODUCED USING A STRUCTURED FABRIC AND ENERGY EFFICIENT PRESSING | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2024-07-04 | — | — | US | disclosed |
| US-20240218604-A1 | SOFT TISSUE PRODUCED USING A STRUCTURED FABRIC AND ENERGY EFFICIENT PRESSING | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2024-07-04 | — | — | US | disclosed |
| US-11959226-B2 | Soft tissue produced using a structured fabric and energy efficient pressing | FIRST QUALITY TISSUE, LLC (US) | 2024-04-16 | — | — | US | disclosed |
| US-11807992-B2 | Soft tissue produced using a structured fabric and energy efficient pressing | FIRST QUALITY TISSUE, LLC (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230265616-A1 | SOFT, LOW LINT, THROUGH AIR DRIED TISSUE AND METHOD OF FORMING THE SAME | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2023-08-24 | — | — | US | disclosed |
| US-11725345-B2 | Method of producing absorbent structures with high wet strength, absorbency, and softness | STRUCTURED I, LLC (US) | 2023-08-15 | — | — | US | disclosed |
| US-11674266-B2 | Soft, low lint, through air dried tissue and method of forming the same | FIRST QUALITY TISSUE, LLC (US) | 2023-06-13 | — | — | US | disclosed |
| US-20160289898-A1 | SOFT THROUGH AIR DRIED TISSUE | JPMORGAN CHASE BANK, N.A., AS AGENT | 2016-10-06 | — | — | US | disclosed |
| US-20160273169-A1 | SOFT THROUGH AIR DRIED TISSUE | JPMORGAN CHASE BANK, N.A., AS AGENT | 2016-09-22 | — | — | US | disclosed |
| US-20160273168-A1 | SOFT THROUGH AIR DRIED TISSUE | JPMORGAN CHASE BANK, N.A., AS AGENT | 2016-09-22 | — | — | US | disclosed |
| US-9382666-B2 | Soft through air dried tissue | FIRST QUALITY TISSUE, LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160145810-A1 | SOFT TISSUE PRODUCED USING A STRUCTURED FABRIC AND ENERGY EFFICIENT PRESSING | FIRST QUALITY TISSUE, LLC | 2016-05-26 | — | — | US | disclosed |
| EP-2879556-A1 | SOFT THROUGH AIR DRIED TISSUE | First Quality Tissue, LLC (US) | 2015-06-10 | — | — | EP | disclosed |
| US-20150059995-A1 | SOFT THROUGH AIR DRIED TISSUE | JPMORGAN CHASE BANK, N.A., AS AGENT | 2015-03-05 | — | — | US | disclosed |
| US-8968517-B2 | Soft through air dried tissue | FIRST QUALITY TISSUE, LLC (US) | 2015-03-03 | — | — | US | disclosed |
| US-20140041820-A1 | SOFT THROUGH AIR DRIED TISSUE | FIRST QUALITY TISSUE, LLC (US) | 2014-02-13 | — | — | US | disclosed |
| WO-2014022848-A1 | SOFT THROUGH AIR DRIED TISSUE | FIRST QUALITY TISSUE, LLC (US) | 2014-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035863-A1 | SOFT, LOW LINT, THROUGH AIR DRIED TISSUE AND METHOD OF FORMING THE SAME | LARP7, SETD7, LGALS7; LGALS7B | FUT7 241/4885EEF2K 3601/4885KCNH2 2106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.